Trial · NCT05964049
pBFS Guided rTMS Therapy for Treatment-resistant Obsessive-Compulsive Disorder
NCT05964049, Not applicable, Unknown, Changping Laboratory
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. pBFS Guided rTMS Therapy for Treatment-resistant Obsessive-Compulsive Disorder. Trials, record NCT05964049. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT05964049
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- pBFS Guided rTMS Therapy for Treatment-resistant Obsessive-Compulsive Disorder
- NCT number
- NCT05964049
- Status
- Unknown
- Phases
- Not applicable
- Enrollment
- 30 participants, estimated
- Lead sponsor
- Changping Laboratory
- Conditions
- Obsessive-Compulsive Disorder, OCD
- Interventions
- active rTMS treatment, sham rTMS treatment
- First posted
- 2023-07-27
- Last updated
- 2023-07-27
Source ClinicalTrials.gov
Registered outcomes6
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | response rates estimated using Yale-Brown Obsessive Compulsive Scale (Y-BOCS) | Baseline, Day 15(immediate post-treatment), 15- and 30-day post-treatment | The Y-BOCS is a validated instrument stratifying the severity of obsessive episodes. This validated questionnaire was used to assess the response rate and remission rate of obsessive episodes. The response is defined as a symptom improvement of ≥35% on Y-BOCS; |
| Secondary | remission rates estimated using Yale-Brown Obsessive Compulsive Scale (Y-BOCS) | Baseline, Day 15(immediate post-treatment), 15- and 30-day post-treatment | Remission was defined as a score \<8. |
| Secondary | Partial response rates estimated using Yale-Brown Obsessive Compulsive Scale (Y-BOCS) | Baseline, Day 15(immediate post-treatment), 15- and 30-day post-treatment | Partial response is defined as a symptom 35% ≥ improvement ≥25% on Y-BOCS |
| Secondary | cognitive change in stroop | Baseline, Day 15(immediate post-treatment) | The Stroop test can be used to measure a person's selective attention capacity and skills, processing speed, and alongside other tests to evaluate overall executive processing abilities |
| Secondary | cognitive change in Hopkins verbal learning test(immediate recall) | Baseline, Day 15(immediate post-treatment) | The Hopkins Verbal Learning Test (HVLT-R) is one such assessment that consists of memorization of a list of words to test the ability to recall immediately after memorization |
| Secondary | cognitive change in Trail-Making Test | Baseline, Day 15(immediate post-treatment) | The test can provide information about visual search speed, scanning, speed of processing, mental flexibility, and executive functioning |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests4
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|---|---|
| Stroop Color-Word Test | Secondary outcome | ConductCognition |
| Trail Making Test A | Secondary outcome | ConductCognition |
| Trail Making Test B | Secondary outcome | ConductCognition |
| Verbal Learning | Secondary outcome | ConductCognition |
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT05964049
GET https://conductscience.org/api/trials/v1/NCT05964049/registered